How compare biologics applied for rheumatic disorders?

نویسندگان

چکیده

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Treatment with biologics during pregnancy in patients with rheumatic diseases

Chronic inflammatory rheumatic diseases frequently affect women of the reproductive age. For these women family planning is an important issue in their life, yet this issue is characterized by a lot of concerns and conflicting information for both patients and doctors. To control disease activity and prevent joint or organ damage, a longterm immunosuppressive therapy is necessary in these patie...

متن کامل

How to Compare Treebanks

Recent years have seen an increasing interest in developing standards for linguistic annotation, with a focus on the interoperability of the resources. This effort, however, requires a profound knowledge of the advantages and disadvantages of linguistic annotation schemes in order to avoid importing the flaws and weaknesses of existing encoding schemes into the new standards. This paper address...

متن کامل

Paraneoplastic Rheumatic Disorders

Received: February 22, 2012 Accepted: February 28, 2012 Correspondence: Ömer Faruk Şendur, M.D. Adnan Menderes Üniversitesi Tıp Fakültesi Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı, 09100 Aydın, Turkey. Tel: +90 256 444 12 56 e-mail: [email protected] ©2012 Turkish League Against Rheumatism. All rights reserved. Altta yatan malign bir hastalık nedeniyle ortaya çıkan, tümör veya metastaz ile ...

متن کامل

How to compare biologic drugs.

This consensus document reviews the evidence on the evaluation of biological drugs. The main conclusions of the group are: a) the current evidence on biological comparisons is based on indirect comparisons and is generally unreliable and with important methodological limitations. Therefore, b) it is considered necessary to amend the regulatory directives in the sense of strongly favoring random...

متن کامل

Biologics and biosimilars: what, why and how?

1Division of Clinical Pharmacology, Department of Medicine and Therapeutics Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong 2Clinical Research Management Office, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong 3Department of Clinical Oncology at the Sir YK Pao Centre for Cancer Hong Ko...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Reumatologia/Rheumatology

سال: 2014

ISSN: 0034-6233

DOI: 10.5114/reum.2014.42796